Telix hopeful for product approvals today posts $33m loss

MELBOURNE: Drug developer Telix is banking on its flagship prostate cancer imaging product ... read more

Cochlear boosts final dividend to $1.40 as sales surge

MELBOURNE: Cochlear investors will see full-year dividends jump close to 60 per cent ... read more

Stockland banks on residential boom says newly insta CEO

SYDNEY: Stockland said a booming residential market will help it boost earnings at ... read more

SA could still beat Victoria to mRNA jab jackpot

MELBOURNE: In the race to manufacture mRNA vaccines onshore, Victoria may be the ... read more